Cigna Group Reports Director Changes and Compensation Updates
Ticker: CI · Form: 8-K · Filed: Oct 20, 2025 · CIK: 1739940
| Field | Detail |
|---|---|
| Company | Cigna Group (CI) |
| Form Type | 8-K |
| Filed Date | Oct 20, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: governance, executive-compensation, board-changes
Related Tickers: CI
TL;DR
Cigna's board saw a director exit and a new one join; exec pay details also updated.
AI Summary
On October 15, 2025, The Cigna Group reported changes in its board of directors and executive compensation arrangements. Specifically, the company announced the departure of a director and the election of a new director, along with updates to the compensatory arrangements for certain named executive officers.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance and executive compensation disclosures, which typically carry low risk.
Key Players & Entities
- The Cigna Group (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- October 15, 2025 (date) — Date of earliest event reported
- 900 Cottage Grove Road (address) — Principal executive offices
- Bloomfield, Connecticut (location) — City and State of principal executive offices
FAQ
Who is the departing director from The Cigna Group's board?
The filing indicates the departure of a director but does not name the individual in the provided text.
Who is the newly elected director to The Cigna Group's board?
The filing mentions the election of a new director but does not provide their name in the provided text.
What specific compensatory arrangements were updated for certain officers?
The filing states that there were updates to compensatory arrangements for certain officers, but the specific details are not included in the provided text.
What is the primary reason for this Form 8-K filing?
This Form 8-K is being filed to report the departure of directors or certain officers, the election of directors, and compensatory arrangements of certain officers.
When was the earliest event reported in this filing?
The earliest event reported in this filing occurred on October 15, 2025.
Filing Stats: 431 words · 2 min read · ~1 pages · Grade level 12.1 · Accepted 2025-10-20 16:16:23
Key Financial Figures
- $0.01 — ich registered Common Stock, Par Value $0.01 CI New York Stock Exchange, Inc.
Filing Documents
- ef20057405_8k.htm (8-K) — 23KB
- 0001140361-25-038670.txt ( ) — 145KB
- ci-20251015.xsd (EX-101.SCH) — 4KB
- ci-20251015_lab.xml (EX-101.LAB) — 21KB
- ci-20251015_pre.xml (EX-101.PRE) — 16KB
- ef20057405_8k_htm.xml (XML) — 4KB
02
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On October 15, 2025, Retired Major General Elder Granger, M.D. informed the Board of Directors (the "Board") of The Cigna Group (the "Company") that he will retire from the Board effective December 31, 2025. General Granger's retirement is consistent with the Board's retirement age policy. General Granger's retirement is not the result of any disagreement with the Company. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. THE CIGNA GROUP Date: October 20, 2025 By: /s/ Nicole S. Jones Name: Nicole S. Jones Title: Executive Vice President, Chief Administrative Officer, and General Counsel